5.77
-0.30
(-4.94%)
At close: January 10 at 4:00:02 PM EST
5.80
+0.03
+(0.52%)
After hours: January 10 at 5:48:43 PM EST
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 1.18M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
SNYDER DAVID S. Chief Financial Officer | Purchase at price 7.19 per share. | Direct | 12,934 | Nov 14, 2024 |
SWAMINATHAN ARUN PH.D. Chief Executive Officer | Purchase at price 7.36 per share. | Direct | 36,797 | Nov 13, 2024 |
GROSSMAN FRED Officer | Purchase at price 7.37 per share. | Direct | 19,973 | Nov 11, 2024 |
SWAMINATHAN ARUN PH.D. Chief Executive Officer | Purchase at price 7.34 per share. | Direct | 36,689 | Nov 11, 2024 |
LEE ANN Director | Purchase at price 3.62 per share. | Indirect | 3,620 | Aug 22, 2023 |
Related Tickers
GANX Gain Therapeutics, Inc.
2.3000
-5.74%
INMB INmune Bio, Inc.
5.49
+3.58%
ACTU Actuate Therapeutics, Inc. Common stock
8.30
+3.75%
APRE Aprea Therapeutics, Inc.
3.6550
-7.47%
ALRN Aileron Therapeutics, Inc.
2.1100
+9.33%
CUE Cue Biopharma, Inc.
1.5100
+4.14%
NGENF NervGen Pharma Corp.
2.1250
+0.24%
TCRX TScan Therapeutics, Inc.
2.7700
-2.81%
PYPD PolyPid Ltd.
3.1000
+3.68%
MRKR Marker Therapeutics, Inc.
2.8300
-1.05%